Is Levetiracetam (Keppra) safe during pregnancy? Generally, yes, with careful monitoring. Studies show low risk, but dosage adjustments are often needed.
By Shubhra Mishra — a mom of two who turned her own confusion during pregnancy into BumpBites, a global mission to make food choices clear, safe, and stress-free for every expecting mother. 💛
Check whether any food is safe during pregnancy with the BumpBites Food Safety Checker.
Quick verdict: ⚠️ Talk to your doctor first. For many pregnant individuals with epilepsy, continuing levetiracetam (Keppra) at an effective dose is often the safest option, as uncontrolled seizures pose significant risks to both parent and baby.
Receiving an epilepsy diagnosis is a lot to process, and if you're also navigating pregnancy, the questions around medication safety can feel overwhelming. Perhaps you've been taking levetiracetam (commonly known by its brand name, Keppra) for years to manage your seizures, and now you're wondering, "is levetiracetam Keppra safe during pregnancy?" Or maybe you've just found out you're pregnant and already took your usual dose, triggering a wave of worry. We understand that feeling of anxiety, especially when it comes to balancing your health with your baby's development.
The good news is that for many expecting parents, levetiracetam is considered one of the safer antiepileptic drugs (AEDs) to use during pregnancy. However, it's crucial to understand that managing epilepsy during pregnancy is a delicate balance. The risks of uncontrolled seizures to both you and your baby—such as oxygen deprivation, trauma from falls, or preterm labor—often outweigh the potential risks associated with the medication itself. That's why the most important first step is always to have an open and honest conversation with your neurologist and obstetrician about your specific situation and medication plan. They can help you weigh the benefits and risks to ensure the best possible outcomes for both you and your little one.
In this article, we'll dive deep into what current research and major health organizations like the American College of Obstetricians and Gynecologists (ACOG) and the UK's National Institute for Health and Care Excellence (NICE) say about whether is levetiracetam Keppra safe during pregnancy. We'll cover safety by trimester, potential risks, recommended dosages, and even discuss safer alternatives and what to consider during breastfeeding. Our goal is to provide you with clear, evidence-based information so you can feel more confident and informed about your choices.
Levetiracetam (Keppra) Pregnancy Safety Snapshot
Trimester / Period
Verdict
Notes
First Trimester
⚠️ Safe with close monitoring
Generally considered one of the safer AEDs. Close monitoring of drug levels and fetal development is essential. Folic acid supplementation is crucial.
Second Trimester
✅ Generally safe
Continued use is typically recommended. Drug levels may decrease as pregnancy progresses, requiring dosage adjustments.
Third Trimester
✅ Generally safe
Similar to the second trimester, dosage adjustments may be needed to maintain seizure control. Discuss labor and delivery plans with your care team.
Breastfeeding
⚠️ Safe with limits / monitoring
Levetiracetam passes into breast milk, but generally in low amounts. Monitor the infant for drowsiness or poor feeding. Most experts consider it compatible with breastfeeding.
What is Levetiracetam (Keppra)?
Levetiracetam, widely recognized by its brand name Keppra, is an antiepileptic drug (AED) used to prevent and control seizures. It belongs to a class of medications known as pyrrolidine derivatives. Unlike some older AEDs that target specific neurotransmitter systems, levetiracetam has a unique mechanism of action, primarily binding to a synaptic vesicle protein called SV2A in the brain. This binding is thought to reduce the release of neurotransmitters that contribute to seizure activity, thereby stabilizing electrical activity in the brain.
This medication is prescribed for various types of seizures, including partial-onset seizures (with or without secondary generalization), myoclonic seizures in people with juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures. It's available in several forms, including oral tablets, extended-release tablets, an oral solution, and an intravenous (IV) formulation. Many people find levetiracetam effective in managing their epilepsy with a relatively favorable side effect profile compared to some other AEDs, making it a common choice for long-term seizure control. Because of its broad spectrum of action and generally good tolerability, it's often a first-line treatment for newly diagnosed epilepsy and is also used as an add-on therapy for those whose seizures are not fully controlled by other medications.
Discussing your medication with your doctor is key when you find out you're pregnant.
Is Levetiracetam Keppra Safe during Pregnancy?
When asking "is levetiracetam Keppra safe during pregnancy?", the answer is generally reassuring, particularly when compared to some older antiepileptic drugs. Current evidence suggests that levetiracetam is one of the safer options for managing epilepsy during pregnancy. Major organizations like the American College of Obstetricians and Gynecologists (ACOG) and the National Institute for Health and Care Excellence (NICE) in the UK often recommend it as a preferred choice, especially for those who are already well-controlled on it.
The primary concern with any medication during pregnancy, especially in the first trimester, is the potential for birth defects (teratogenicity). Studies and large pregnancy registries, such as the North American Antiepileptic Drug (NAAED) Pregnancy Registry, have largely shown that levetiracetam is associated with a low risk of major congenital malformations. While no medication can be declared 100% risk-free, the observed rates of birth defects with levetiracetam are comparable to those in the general population, or only slightly elevated, which is a significant finding for expecting parents managing epilepsy.
However, "safe" doesn't mean "without any considerations." The most critical aspect is maintaining effective seizure control throughout your pregnancy. Uncontrolled seizures pose significant risks to both you and your developing baby, including trauma, falls, oxygen deprivation (hypoxia), and even miscarriage or preterm birth. Therefore, the consensus among healthcare providers is that for pregnant individuals with epilepsy, continuing an effective antiepileptic drug, like levetiracetam, at a dose that prevents seizures is almost always safer than stopping the medication and risking uncontrolled seizures. Any decision to change or stop medication should *only* be made in close consultation with your neurologist and obstetrician, never on your own.
Is Keppra safe to take during the first trimester of pregnancy?
The first trimester, specifically weeks 3 to 8, is a critical period for fetal organ development (organogenesis). This is why many pregnant individuals are particularly concerned about medication exposure during this time. For those wondering "is levetiracetam Keppra safe during pregnancy" in these early weeks, the data is largely favorable. Levetiracetam is generally considered one of the lower-risk antiepileptic drugs for use during the first trimester, with studies showing a low incidence of major congenital malformations.
However, close monitoring is still essential. Your healthcare provider will likely recommend regular blood tests to check your levetiracetam levels. Pregnancy can alter how your body processes medication, often leading to lower drug concentrations in your blood, which could potentially reduce seizure control. Adjustments to your dosage may be necessary to maintain therapeutic levels and prevent seizures. Additionally, it's vital to begin high-dose folic acid supplementation (typically 4 mg/day, or 4000 mcg) at least one month before conception and continue through the first trimester, and ideally throughout pregnancy, as recommended by organizations like the CDC and ACOG. While levetiracetam isn't strongly linked to neural tube defects in the same way some other AEDs are, folic acid is a crucial nutrient for all pregnancies and particularly important for those taking AEDs.
Is Keppra safe to take during the second trimester of pregnancy?
As you move into your second trimester, the primary organ development period has passed, and the risk of major birth defects from medication exposure generally decreases. If you've been taking levetiracetam, continuing your medication is almost always recommended to maintain seizure control. Your medical team will continue to monitor your levetiracetam levels, as they can fluctuate throughout pregnancy due to changes in blood volume and kidney function. Dosage adjustments might still be needed to ensure the medication remains effective. The focus during this trimester remains on ensuring your seizures are well-controlled while monitoring fetal growth and development through routine ultrasounds.
Is Keppra safe to take during the third trimester of pregnancy?
During the third trimester, the main concern shifts slightly towards maintaining seizure control as your body prepares for labor and delivery, and monitoring for any potential effects on the baby's growth. Levetiracetam continues to be generally safe for use during this period. Your doctor will likely maintain close surveillance of your drug levels and make any necessary dosage adjustments. It's also a good time to discuss your labor and delivery plan with your healthcare team. They can advise on how your medication schedule might be managed around delivery and ensure that appropriate monitoring is in place for both you and your newborn.
Can you breastfeed while taking Levetiracetam?
For many new parents, the question of whether medication is safe for breastfeeding is a significant one. The good news is that for those asking, "is levetiracetam Keppra safe during pregnancy?" and beyond, most experts consider levetiracetam compatible with breastfeeding. Levetiracetam does pass into breast milk, but generally in relatively low amounts. The amount of drug the infant receives through breast milk is typically small and is not usually associated with significant adverse effects.
However, it's always wise to monitor your baby for any signs of drowsiness, poor feeding, or unusual irritability. If you notice any of these symptoms, discuss them with your pediatrician immediately. The benefits of breastfeeding, combined with the low risk associated with levetiracetam, generally support continuing both the medication and breastfeeding. Organizations like the American Academy of Pediatrics (AAP) and the UK's National Health Service (NHS) often list levetiracetam as a medication that can be used cautiously during lactation. As always, consult with your healthcare provider or a lactation consultant for personalized advice.
Recommended Keppra dosage for pregnant women
There isn't a single "recommended Keppra dosage for pregnant women" that applies to everyone, as dosage is highly individualized and depends on several factors, including the type and frequency of seizures, the individual's response to the medication, and their body's metabolism. However, the general principle is to use the lowest effective dose that controls seizures. This approach minimizes fetal exposure while maximizing seizure control, which is paramount.
During pregnancy, physiological changes can significantly impact drug metabolism. Increased blood volume, changes in kidney function, and altered liver enzyme activity can lead to a decrease in levetiracetam levels in the blood. This means that a dose that was previously effective for seizure control might become sub-therapeutic (too low) during pregnancy. Therefore, your neurologist will likely recommend therapeutic drug monitoring (TDM) – regular blood tests to measure your levetiracetam levels. Based on these levels and your seizure frequency, your dosage may need to be adjusted upwards, especially during the second and third trimesters, to maintain seizure freedom. After delivery, your dosage will likely be reduced back to your pre-pregnancy level, as your body's metabolism returns to normal.
Is generic Levetiracetam as effective as Keppra during pregnancy?
The question of whether generic levetiracetam is as effective as brand-name Keppra during pregnancy is a common one, and it's a valid concern for any medication where consistent blood levels are crucial. Generic medications are required by the FDA to be bioequivalent to their brand-name counterparts, meaning they deliver the same amount of active ingredient into the bloodstream over the same period. For most medications, this means generics are considered equally effective and safe.
However, with antiepileptic drugs, there's a long-standing debate among some neurologists and patients about whether small differences in inactive ingredients or manufacturing processes could lead to subtle shifts in drug absorption or blood levels, potentially impacting seizure control, especially in sensitive situations like pregnancy. While current evidence generally supports the bioequivalence of generic levetiracetam, some providers may recommend sticking with the brand-name Keppra if you were well-controlled on it pre-pregnancy, or if you experience a change in seizure frequency after switching to a generic. If you are considering switching from brand-name Keppra to generic levetiracetam (or vice versa) during pregnancy, it's crucial to discuss this with your neurologist. They may recommend closer monitoring of your drug levels and seizure activity during the transition.
What are the risks of taking Levetiracetam during pregnancy?
While levetiracetam is generally considered one of the safer antiepileptic drugs for use during pregnancy, it's important to be aware of the potential risks, even if they are low. The primary concerns revolve around the developing fetus and the balance of seizure control. The most significant risk associated with *not* taking effective medication is uncontrolled seizures, which pose a far greater danger to both parent and baby than the medication itself.
Regarding fetal exposure, large pregnancy registries and studies have shown that levetiracetam has a relatively low risk of causing major congenital malformations (birth defects), with rates generally comparable to the background risk in the general population (around 2-3%). This is a reassuring finding compared to some older AEDs that carry higher risks. However, no medication is entirely without risk, and individual responses can vary.
Beyond major malformations, there's ongoing research into potential neurodevelopmental outcomes. Some studies have explored whether exposure to AEDs in utero, including levetiracetam, could subtly impact a child's cognitive development or increase the risk of conditions like autism spectrum disorder or ADHD. The evidence for levetiracetam specifically is mixed, with some studies showing no increased risk and others suggesting a slight, non-specific association. It's challenging to separate the effects of the medication from the underlying epilepsy itself, as epilepsy can independently influence neurodevelopment. The current consensus is that any potential neurodevelopmental risks associated with levetiracetam are likely to be small, and certainly less than the known risks of uncontrolled maternal seizures.
Potential side effects of Keppra on a developing fetus
When considering the potential side effects of Keppra on a developing fetus, it's important to distinguish between major congenital malformations and more subtle developmental effects. As discussed, levetiracetam is associated with a low risk of major birth defects, making it a preferred choice for many pregnant individuals with epilepsy. However, some areas of ongoing research and discussion include:
Minor Anomalies: While major birth defects are rare, some studies have looked at the possibility of minor anomalies, which are usually of no medical consequence. The rates of these are generally low and often similar to background rates.
Neurodevelopmental Outcomes: This is an area of active research for all AEDs. Some studies have investigated whether prenatal exposure to levetiracetam might be linked to subtle effects on a child's cognitive development, language skills, or behavior (e.g., increased risk of ADHD or autism traits). However, the findings are not consistent, and it's difficult to isolate the effect of the drug from other factors like the mother's underlying epilepsy, genetics, or other medications. Many studies conclude that if there is an effect, it is likely small and less significant than the risks associated with uncontrolled seizures.
Growth Restriction: Some AEDs have been linked to a slight reduction in fetal growth. While levetiracetam is not strongly associated with this, your healthcare provider will monitor your baby's growth through routine ultrasounds, as is standard in any pregnancy.
It's crucial to remember that these are potential, often low, risks, and the decision to continue levetiracetam during pregnancy is made because the risks of *uncontrolled seizures* for both the parent and the baby are generally much higher. Your medical team will continuously weigh these factors to ensure the safest possible outcome.
Always discuss your medication plan with your healthcare provider, especially when pregnant.
Safer alternatives to Keppra for epilepsy during pregnancy
While levetiracetam (Keppra) is often considered a first-line option or a relatively safe choice during pregnancy, some individuals may need to consider alternatives due to side effects, lack of seizure control, or other medical reasons. It's important to reiterate that any change in medication should *only* be made under the guidance of your neurologist and obstetrician, ideally before conception, but if not, as early in pregnancy as possible. The goal is always to find the lowest effective dose of the safest possible medication to prevent seizures.
Here are some other antiepileptic drugs that are often considered to have a more favorable safety profile during pregnancy compared to older AEDs like valproic acid:
Lamotrigine (Lamictal): This is frequently cited as one of the safest AEDs for pregnancy, often considered a first-line alternative to levetiracetam. It has a low risk of major congenital malformations and is generally well-tolerated. However, its levels can significantly drop during pregnancy, requiring close monitoring and dosage adjustments.
Carbamazepine (Tegretol): While historically linked to a slightly increased risk of neural tube defects (like spina bifida), this risk is significantly reduced with adequate folic acid supplementation. It's still considered a reasonable option for some, particularly if it's the only medication that effectively controls their seizures.
Oxcarbazepine (Trileptal): Chemically similar to carbamazepine, oxcarbazepine may have a slightly better safety profile regarding major malformations. It's often considered a good alternative for partial-onset seizures.
Gabapentin (Neurontin): Although primarily used for neuropathic pain, gabapentin is also an AED. It has a generally favorable safety profile in pregnancy, with a low risk of birth defects. However, it's not effective for all seizure types.
Phenytoin (Dilantin): This is an older AED with a known association with specific fetal syndromes (Fetal Hydantoin Syndrome), including facial anomalies, limb defects, and developmental delays, particularly with higher doses. It's generally avoided as a first-line choice in pregnancy if other effective options are available, but may be continued if it's the only drug that controls severe seizures.
The choice of medication is highly individualized, balancing the specific seizure type, the parent's response to treatment, and the known risks during pregnancy. Your healthcare team will help you navigate these complex decisions.
Related items — safety at a glance
Understanding the safety of levetiracetam (Keppra) in pregnancy often involves comparing it to other antiepileptic drugs (AEDs) and related factors. Here's a quick overview of how some common AEDs and related considerations stack up regarding pregnancy safety:
Pregnancy Safety of Related Antiepileptic Drugs and Factors
Item
Verdict
Notes on Pregnancy Safety
Lamotrigine (Lamictal)
✅ Generally preferred
Often considered one of the safest AEDs during pregnancy; low risk of major birth defects. Levels require close monitoring.
Valproic Acid (Depakote)
❌ Best avoided (unless no other option)
Highest risk of major congenital malformations (e.g., neural tube defects, facial clefts) and significant neurodevelopmental risks (e.g., lower IQ, autism). Generally avoided in women of childbearing potential.
Phenytoin (Dilantin)
⚠️ Safe with limits / Close monitoring
Associated with Fetal Hydantoin Syndrome (facial abnormalities, growth restriction). Generally avoided if other options are available, especially at higher doses.
Carbamazepine (Tegretol)
⚠️ Safe with limits / Close monitoring
Increased risk of neural tube defects (e.g., spina bifida), though lower than valproic acid. High-dose folic acid supplementation is crucial.
Topiramate (Topamax)
❌ Best avoided (unless no other option)
Increased risk of oral clefts (cleft lip/palate) and potentially other malformations. Generally avoided in pregnancy if possible.
Gabapentin (Neurontin)
✅ Generally safe
Considered to have a low risk of major birth defects. Often used for neuropathic pain but also as an AED.
Folic Acid
✅ Essential
Crucial supplement (high dose, 4mg/day) for all pregnant individuals taking AEDs, starting before conception, to reduce neural tube defect risk.
Epilepsy
⚠️ Requires careful management
The underlying condition itself poses risks (e.g., seizures) to pregnancy, necessitating effective treatment.
Seizures
❌ Best avoided (uncontrolled)
Uncontrolled seizures during pregnancy carry significant risks for both parent (trauma, hypoxia) and baby (hypoxia, miscarriage, preterm birth).
Antiepileptic Drugs (AEDs)
⚠️ Individualized risk/benefit
A category of medications; safety varies widely by specific drug. The goal is to use the safest effective AED at the lowest effective dose.
Myth vs. fact
When you're pregnant and managing a condition like epilepsy, there's a lot of information—and misinformation—out there. Let's clear up some common myths about levetiracetam (Keppra) and pregnancy:
Myth: You should stop taking Keppra as soon as you find out you're pregnant to protect the baby.
Fact: Abruptly stopping antiepileptic medication like Keppra is extremely dangerous and can lead to severe, uncontrolled seizures. Uncontrolled seizures pose a much greater risk to both you and your baby than continuing your medication under medical supervision. Always consult your neurologist and obstetrician immediately if you discover you're pregnant while on Keppra. They will help you weigh the risks and benefits and adjust your treatment plan safely.
Myth: All antiepileptic drugs carry the same high risk of birth defects.
Fact: The risk of birth defects varies significantly among different antiepileptic drugs. While some older AEDs like valproic acid are associated with higher risks, levetiracetam (Keppra) is considered one of the safer options, with a low risk of major congenital malformations comparable to the general population. This is why drug choice and dosage are so carefully considered by your medical team.
Myth: Taking Keppra means you can't breastfeed your baby.
Fact: Levetiracetam is generally considered compatible with breastfeeding. While it does pass into breast milk, the amount is typically low and usually doesn't cause significant issues for the baby. Most experts agree that the benefits of breastfeeding often outweigh the minimal risks. However, always monitor your baby for drowsiness or feeding difficulties and discuss any concerns with your pediatrician.
Key takeaways
Levetiracetam (Keppra) is generally considered one of the safer antiepileptic drugs for use during pregnancy, with a low risk of major birth defects.
The risks of uncontrolled seizures to both the pregnant individual and the baby are usually much higher than the risks associated with continuing levetiracetam.
Never stop or change your Keppra dosage without first consulting your neurologist and obstetrician.
Close monitoring of levetiracetam blood levels is essential throughout pregnancy, as dosage adjustments may be needed to maintain seizure control.
High-dose folic acid supplementation (4 mg/day) is crucial for all pregnant individuals taking antiepileptic drugs, starting before conception.
Levetiracetam is typically considered compatible with breastfeeding, but monitor your baby for any signs of drowsiness or poor feeding.
Frequently asked questions
Can Keppra cause birth defects?
Studies and pregnancy registries have shown that levetiracetam (Keppra) is associated with a low risk of major congenital malformations, generally comparable to the background risk in the general population. While no medication is 100% risk-free, it's considered one of the safer antiepileptic drugs in terms of birth defect risk during pregnancy.
Is Keppra safe during breastfeeding?
Yes, levetiracetam (Keppra) is generally considered compatible with breastfeeding. It does pass into breast milk, but typically in low amounts that are not usually associated with significant adverse effects in the infant. It's still important to monitor your baby for any signs of drowsiness or poor feeding and consult your pediatrician.
What are the risks of taking seizure medication during pregnancy?
The risks of taking seizure medication during pregnancy vary widely by drug. Some older medications carry higher risks of birth defects or neurodevelopmental issues. However, the greatest risk often comes from *uncontrolled seizures*, which can lead to oxygen deprivation, trauma, miscarriage, or preterm birth for the baby, and injury to the parent. The goal is always to find the safest effective medication.
Do I need to stop Keppra if I'm pregnant?
No, you should absolutely not stop Keppra if you're pregnant without first consulting your neurologist and obstetrician. Abruptly stopping can lead to severe, uncontrolled seizures, which are very dangerous for both you and your baby. Your healthcare team will work with you to develop a safe and effective treatment plan.
What is the best seizure medication for pregnancy?
There isn't a single "best" seizure medication for pregnancy, as the choice is highly individualized. However, levetiracetam (Keppra) and lamotrigine (Lamictal) are often considered first-line options due to their relatively low risk of birth defects and good safety profiles. The best medication is the one that effectively controls your seizures with the lowest possible risk to your baby.
Does Keppra affect fertility?
Current evidence suggests that levetiracetam (Keppra) does not significantly affect fertility in either men or women. Unlike some other antiepileptic drugs that can cause hormonal changes or impact reproductive function, levetiracetam is generally considered to have a neutral effect on fertility. If you have concerns about fertility, discuss them with your healthcare provider.
Is Levetiracetam a high-risk pregnancy drug?
No, levetiracetam is generally *not* considered a high-risk pregnancy drug. In fact, compared to many other antiepileptic medications, it's categorized as having a relatively low risk profile for use during pregnancy. The risks associated with uncontrolled seizures are typically much higher than those linked to taking levetiracetam under medical supervision.
When to call your doctor
Managing epilepsy during pregnancy requires close collaboration with your healthcare team. While levetiracetam is generally considered safe, there are specific situations when you should promptly contact your doctor:
Any change in seizure frequency or type: If you experience new seizures, more frequent seizures, or a change in your usual seizure pattern, contact your neurologist immediately. This could indicate your medication levels are too low.
New or worsening side effects: If you develop severe dizziness, extreme fatigue, mood changes, or any other concerning side effects that you believe are related to your Keppra.
Concerns about your baby's movements or growth: While regular monitoring is standard, if you notice a significant decrease in fetal movement or have any other worries about your baby's well-being.
Signs of allergic reaction: If you develop a rash, hives, swelling, or difficulty breathing after taking Keppra, seek immediate medical attention.
Any questions or anxieties: Never hesitate to reach out to your healthcare provider if you have questions, need reassurance, or are feeling overwhelmed about your medication or pregnancy.
Remember, this information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
References
American College of Obstetricians and Gynecologists (ACOG). (2020). Epilepsy in Pregnancy. Committee Opinion No. 813.
National Institute for Health and Care Excellence (NICE). (2012). Epilepsy in adults, children and young people: diagnosis and management. (Updated 2023).
Centers for Disease Control and Prevention (CDC). (2023). Epilepsy & Pregnancy.
North American Antiepileptic Drug (NAAED) Pregnancy Registry. (Ongoing research and publications).
FDA Drug Labels for Levetiracetam (Keppra).
American Academy of Pediatrics (AAP). (2022). Medications and Breast Milk.
British National Formulary (BNF). (Ongoing guidance on drug use in pregnancy and breastfeeding).
Not sure about the label on Is Levetiracetam Keppra Safe During Pregnancy products?
Snap the ingredients list and SafeFilter checks every ingredient for your stage — only 3 free scans this month, then you're locked until reset. Unlimited from $7/mo or $50/yr.
When Shubhra Mishra was expecting her first child in 2016, she was overwhelmed by conflicting food advice — one site said yes, another said never. By the time her second baby arrived in 2019, she realized millions of mothers face the same confusion.
That sparked a five-year journey through clinical nutrition papers, cultural diets, and expert conversations — all leading to BumpBites: a calm, compassionate space where science meets everyday motherhood.
Her long-term vision is to build a global community ensuring safe, supported, and free deliveriesfor every mother — because no woman should face pregnancy alone or uninformed. 🌿
🌍 Stand with mothers, shape safer guidance
Join a small circle of experts who review BumpBites articles so expecting parents everywhere can decide with confidence.